• Study protocols (Phase I-IV)   
• Monitoring plans for NIS / NIS-PASS / PMOS   
• Clinical Investigation Plan (CIP) / clinical trial protocol for medical devices   
• Study documents, such as patient information and informed consent forms, manuals, etc.   
• Forms for data collection outside the CRF, such as questionnaires or patient diaries   
• Submission documents for ethics committees and authorities   
• SOPs customised to your needs   
• Final reports and interim reports for clinical studies (Clinical Study Reports) and clinical investigation reports for medical devices (Clinical Investigation Report – CIR)  
• Reports for non-interventional studies, questionnaire studies, retrospective data collection and a variety of other research projects   
• Progress Reports   
• Investigator’s Brochure / Investigator’s Information / Investigator’s Brochure   
• Lay summaries of clinical study results   
• Newsletter for communication with your study team  

Adapting the manuscript to the requirements of the respective journal guarantees the best possible acceptance of your publication.   

Scientific and medical texts/documents are equally convincing in terms of content, language and structure, and require a broad background knowledge and high linguistic competence in addition to a structured working method. Our publication preparation services include  

• Abstracts  
• Publications such as original articles, short communications or literature reviews  
• Popular presentations for the general public  
• Posters  
• PowerPoint presentations  
• Training documents  
• Review of publications, including adaptation to the requirements of the journal  
• Support in specific areas of your publication activities, such as literature research, communication with reviewers, etc. 

Selected references

• Horner A, et al, Physical Activity, Depression and Quality of Life in COPD – Results from the CLARA II Study. Int J Chron Obstruct Pulmon Dis. 2023 Nov; 18:2755-2767t  
• Backer V, et al. A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19. Lancet Reg Health Eur. 2021 Apr;4:100084.  
• Horner A, et al. Quality of Life and Limitations in Daily Life of Stable COPD Outpatients in a Real-World Setting in Austria – Results from the CLARA Project. Int J Chron Obstruct Pulmon Dis. 2020 Jul;15:1655-1663.   
• Essl, A., et al. Psoriasis and IgE-mediated allergy: correlation or mutual inhibition?. Wien Klin Wochenschr 133. 2020 Jul;2021: 997–1003  
• Sator P., Safety and tolerability of adalimumab for the treatment of psoriasis: a review summarizing 15 years of real-life experience. Ther Adv Chronic Dis. 2018 Aug; 9(8): 147–158.